Transaction #12780 · Form 4 · 0001733614-25-000004
UTAH MEDICAL PRODUCTS INC · Stock award · Employee Stock Option - Right to Buy
UTAH MEDICAL PRODUCTS INC · Transacted October 31, 2025 · Filed November 25, 2025
What does this filing report?
An SEC Form 4 filing for UTAH MEDICAL PRODUCTS INC records a stock award involving Employee Stock Option - Right to Buy on October 31, 2025. The reported quantity was 500. The filing date is November 25, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- UTAH MEDICAL PRODUCTS INC
- Company CIK
- 0000706698
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 500
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 5,600
- Ownership description
- Not reported
- SEC acceptance time
- Nov 25, 2025, 6:25 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Koopman Brian ↗
Principal Financial Officer
CIK 0001733614
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 500
- Conversion / exercise price
- 58.1
- Exercise date
- January 1, 2030
- Expiration date
- October 31, 2035
Filing footnotes & remarks
- F1
- Option will vest 25% on 1/1/27, and an additional 6.25% on 4/1/27 and the first day of each calendary quarter thereafter. Fully exercisable on 1/1/30.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.